BackComprehensive Study Notes: Recombinant DNA Technology, Microbial Control, Antimicrobial Drugs, and Epidemiology
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Chapter 8: Recombinant DNA Technology
Recombinant Vectors and Gene Insertion
Recombinant DNA technology involves combining DNA from different sources to produce new genetic combinations. A vector is a DNA molecule used to carry foreign genetic material into another cell.
Vectors are typically plasmids or viruses that can replicate within a host cell.
To produce a recombinant vector containing a human gene insert:
Isolate the gene of interest from human DNA.
Cut both the vector and the gene with the same restriction enzyme to create compatible ends.
Ligate the gene into the vector using DNA ligase.
Introduce the recombinant vector into a host cell (e.g., Escherichia coli).
Example: Inserting the human insulin gene into a bacterial plasmid to produce insulin.
Reverse Transcriptase in Gene Cloning
Reverse transcriptase is an enzyme that synthesizes complementary DNA (cDNA) from an RNA template.
Used to produce cDNA from eukaryotic mRNA, which lacks introns.
Allows expression of eukaryotic genes in prokaryotes, which cannot process introns.
Example: Production of human growth hormone in bacteria.
Polymerase Chain Reaction (PCR)
PCR is a technique used to amplify specific DNA sequences exponentially.
Steps:
Denaturation: Heat to separate DNA strands.
Annealing: Cool to allow primers to bind to target sequences.
Extension: DNA polymerase synthesizes new DNA strands.
Thermus aquaticus provides Taq polymerase, a heat-stable enzyme essential for PCR.
Equation: (where N is the number of DNA copies after n cycles)
Gel Electrophoresis
Gel electrophoresis separates DNA fragments by size using an electric field.
DNA samples are loaded into a gel matrix and subjected to an electric current.
Smaller fragments migrate faster toward the positive electrode.
Used for DNA analysis, fingerprinting, and checking PCR products.
Northern Blot vs. Southern Blot
Southern Blot: Detects specific DNA sequences in DNA samples.
Northern Blot: Detects specific RNA sequences in RNA samples.
Both involve transferring nucleic acids to a membrane and probing with labeled DNA or RNA probes.
DNA Fingerprinting
DNA fingerprinting is a technique for identifying individuals based on unique DNA patterns.
Uses restriction fragment length polymorphism (RFLP) analysis or PCR-based methods.
Applications: Forensics, paternity testing, identification of remains.
Key Definitions
Recombinant DNA: DNA molecules formed by laboratory methods of genetic recombination.
Xenotransplantation: Transplantation of organs or tissues between different species.
Transgenic Organisms: Organisms that contain genes from other species.
DNA Ligase: Enzyme that joins DNA fragments together.
Restriction Enzyme: Enzyme that cuts DNA at specific sequences.
cDNA: Complementary DNA synthesized from an RNA template.
Mutagen: Agent that causes mutations in DNA.
Antisense RNA: RNA molecule complementary to a specific mRNA, used to block translation.
DNA Polymerase: Enzyme that synthesizes DNA molecules.
Splicing: Removal of introns from pre-mRNA in eukaryotes.
Plasmid: Small, circular DNA molecule in bacteria, often used as a vector.
DNA Probe: Labeled DNA or RNA sequence used to detect complementary sequences.
Chapter 9: Controlling Microbial Growth in the Environment
Characteristics of Ideal Antimicrobial Agents
Effective against a wide range of microbes
Non-toxic to humans and animals
Stable during storage
Inexpensive and easy to use
Physical Methods of Microbial Control
Heat: Moist heat (autoclaving, boiling), dry heat (oven)
Filtration: Removal of microbes from air or liquids
Radiation: Ionizing (gamma rays, X-rays) and non-ionizing (UV light)
Desiccation: Drying to inhibit microbial growth
Lyophilization: Freeze-drying for preservation
Chemical Methods of Microbial Control
Alcohols: Denature proteins, disrupt membranes
Halogens: Oxidize cell components (chlorine, iodine)
Phenolics: Disrupt cell walls and membranes
Oxidizing agents: Peroxides, ozone
Heavy metals: Inactivate proteins
Microbial Death Rate and Time
Microbial death rate: The rate at which microbes are killed under specific conditions.
Microbial death time: The time required to kill a population of microbes.
-static: Inhibits growth (e.g., bacteriostatic)
-cidal: Kills microbes (e.g., bactericidal)
Inactivation of Protozoal Cysts and Bacterial Endospores
Protozoal cysts: Require prolonged boiling or chemical treatment.
Bacterial endospores: Require autoclaving (121°C, 15 psi, 15 min) or strong chemicals.
Biosafety Levels
Biosafety Level | Description |
|---|---|
BSL-1 | Non-pathogenic microbes; minimal precautions |
BSL-2 | Moderate risk; lab coats, gloves, eye protection |
BSL-3 | Serious or potentially lethal pathogens; biosafety cabinets |
BSL-4 | High-risk, life-threatening agents; full-body suits, specialized facilities |
Relative Susceptibility of Microbes
Most resistant: Prions, bacterial endospores, mycobacteria
Most susceptible: Enveloped viruses, Gram-positive bacteria
Tests for Efficacy of Antiseptics and Disinfectants
Use-dilution test
Disk-diffusion (Kirby-Bauer) test
Phenol coefficient test
Key Definitions
Antiseptic: Chemical used on living tissue to reduce infection risk.
Disinfectant: Chemical used on inanimate objects to destroy microbes.
Filtration: Physical removal of microbes from liquids or air.
Lyophilization: Freeze-drying for preservation.
Desiccation: Drying to inhibit microbial growth.
Ionizing radiation: High-energy radiation that creates ions, damages DNA.
Non-ionizing radiation: UV light; causes thymine dimers in DNA.
Disinfect: To eliminate most or all pathogens on inanimate objects.
Sanitize: To reduce microbial population to safe levels.
Degerm: Mechanical removal of microbes from a surface.
Aseptic: Free of contamination by pathogens.
Chapter 10: Antimicrobial Drugs
Types of Antimicrobial Agents
Antibacterials: Most numerous; target bacteria.
Antifungals, antivirals, antihelminthics, antiprotozoals: Fewer agents due to similarities between eukaryotic pathogens and host cells.
Fewest agents: Antivirals, because viruses use host cell machinery.
Kirby-Bauer Susceptibility Test
Assesses the effectiveness of antibiotics against specific bacteria.
Antibiotic-impregnated disks are placed on an agar plate inoculated with bacteria.
Zones of inhibition indicate susceptibility.
Mechanisms of Action of Antimicrobial Drugs
Inhibition of cell wall synthesis (e.g., beta-lactams)
Inhibition of protein synthesis (e.g., tetracyclines)
Disruption of cell membrane (e.g., polymyxins)
Inhibition of nucleic acid synthesis (e.g., quinolones, anti-sense nucleic acids)
Inhibition of metabolic pathways (e.g., sulfonamides)
Selective Toxicity
Ability of a drug to target microbes without harming the host.
Beta-lactam, Sulfonamide, and Antisense Nucleic Acid Antimicrobials
Beta-lactams: Inhibit cell wall synthesis (e.g., penicillins).
Sulfonamides: Inhibit folic acid synthesis (competitive inhibition).
Antisense nucleic acids: Bind to mRNA, block translation.
Development of Antibiotic Resistance
Occurs via mutation or acquisition of resistance genes (e.g., R-plasmids).
Beta-lactamase: Enzyme that inactivates beta-lactam antibiotics.
Efflux pumps: Transport antibiotics out of the cell.
Natural selection favors resistant bacteria in the presence of antibiotics.
Advantages of Semi-synthetic and Synthetic Drugs
Improved efficacy, reduced side effects, broader spectrum, or overcoming resistance.
Broad vs. Narrow Spectrum Antibiotics
Broad-spectrum: Effective against a wide range of microbes.
Narrow-spectrum: Effective against specific groups.
Chapter 14: Infection, Infectious Diseases, and Epidemiology
Types of Symbiosis
Mutualism: Both organisms benefit.
Parasitism: One benefits, one is harmed.
Commensalism: One benefits, other is unaffected.
Amensalism: One is harmed, other is unaffected.
Opportunistic Pathogens
Pathogens that cause disease only when the host's defenses are compromised.
Signs vs. Symptoms
Signs: Objective, measurable (e.g., fever, rash).
Symptoms: Subjective, felt by patient (e.g., pain, fatigue).
Epidemiological Terms
Endemic: Constantly present in a population.
Sporadic: Occurs occasionally.
Index case: First identified case in an outbreak.
Pandemic: Worldwide epidemic.
Prevalence: Total cases at a given time.
Incidence: New cases over a period of time.
Epidemic: Sudden increase in cases.
Epidemiology: Study of disease patterns in populations.
Snow’s Epidemiological Study of Cholera (1854)
John Snow traced a cholera outbreak in London to a contaminated water pump, founding modern epidemiology.
Nosocomial Infections and Related Terms
Nosocomial infections: Acquired in healthcare settings.
Etiology: Study of disease causes.
Hand hygiene: Critical for infection prevention.
Pathogenicity: Ability to cause disease.
Virulence: Degree of pathogenicity.
Virulence factors: Traits that enhance pathogenicity (e.g., toxins, capsules).
Modes of Infectious Disease Transmission
Direct contact: Person-to-person
Indirect contact: Via fomites (inanimate objects)
Droplet transmission
Vector transmission: By arthropods
Arthropod Vectors
Biological vectors: Transmit pathogens and are part of the pathogen's life cycle (e.g., mosquitoes for malaria).
Mechanical vectors: Carry pathogens on body surfaces (e.g., flies).
Portals of Entry and Exit
Entry: Skin, mucous membranes, placenta, parenteral route
Exit: Respiratory tract, gastrointestinal tract, urogenital tract, blood
Axenic Sites in the Human Body
Normally microbe-free: blood, cerebrospinal fluid, alveoli, body tissues
Acquisition of Normal Flora in Babies
During birth, breastfeeding, and contact with caregivers and environment.
Stages of Infectious Disease
Incubation, prodromal, illness, decline, convalescence
Endotoxins vs. Exotoxins
Endotoxins: Lipopolysaccharide (LPS) from Gram-negative bacteria; released on cell death.
Exotoxins: Proteins secreted by bacteria; highly toxic (e.g., botulinum toxin).
Probiotics
Live microorganisms that confer health benefits by restoring normal flora and inhibiting pathogens.
Contributions of Key Scientists
Snow: Epidemiology of cholera
Domagk: Discovered sulfa drugs
Ehrlich: Developed first chemotherapeutic agent (Salvarsan)
Fleming: Discovered penicillin
Waksman: Discovered streptomycin
Additional Key Definitions
Transient microbiota: Microbes present temporarily
Resident microbiota: Microbes normally present
Iatrogenic: Resulting from medical procedures
Reservoir: Source of pathogen
Pathogen: Disease-causing organism
Microbial antagonism: Competition between microbes
Synergism: Cooperative interaction between organisms
Selective toxicity: Drug targets pathogen, not host
Cross-resistance: Resistance to multiple drugs via similar mechanisms
Fomite: Inanimate object transmitting pathogens